*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.
Medtronic's upcoming earnings report on August 19th is poised to capture attention, particularly as the company navigates a challenging healthcare landscape with a market cap of approximately $119 billion. Analysts are forecasting an EPS of $1.23, yet the whisper number suggests a slightly more optimistic outlook at $1.27, indicating a subtle undercurrent of confidence among investors. With revenue projections set at $8.38 billion, Medtronic's ability to meet or exceed these expectations will be closely scrutinized, especially in light of its strategic focus on innovation and expansion in emerging markets. As the medical device giant continues to leverage its robust portfolio to drive growth, the market will be keen to see if these efforts translate into tangible financial performance, aligning with or surpassing the whisper number's more bullish sentiment.
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Website: https://www.medtronic.com
Average Sentiment Score:
Overall Sentiment: